Challenges to Fda's Ability to Monitor and Inspect Foreign Clinical Trials
Washington, DC: U.S. Department of Health and Human Services, Office of Inspector General, 2010. 44 p. [Online]. Accessed: http://oig.hhs.gov/oei/reports/oei-01-08-00510.pdf [16 June 2011]
Permanent LinkFind in a Library
Showing items related by title, author, creator and subject.
Unknown author (2002-10-24)
Protecting Clinical Research and Human Participants: Considerations for Domestic and Foreign Clinical Trials Beach, Judith E. (2002)In recent years there has been a shift in focus from national and international "Ethics Influentials" related to the approval of life-saving therapies to a national and international reassessment of the conduct of clinical ...
Studying Treatments for AIDS: New Challenges for Clinical Trials: A Panel Discussion at the 1990 Annual Meeting of the Society for Clinical Trials Ellenberg, Susan S.; Cooper, Ellen; Eigo, James; Finkelstein, Dianne M. (1992-08)